ES2063713A1 - Ampolla y solucion para infusion de acido tioctico en forma de las sales solubles en agua del acido tioctico. - Google Patents

Ampolla y solucion para infusion de acido tioctico en forma de las sales solubles en agua del acido tioctico.

Info

Publication number
ES2063713A1
ES2063713A1 ES09302159A ES9302159A ES2063713A1 ES 2063713 A1 ES2063713 A1 ES 2063713A1 ES 09302159 A ES09302159 A ES 09302159A ES 9302159 A ES9302159 A ES 9302159A ES 2063713 A1 ES2063713 A1 ES 2063713A1
Authority
ES
Spain
Prior art keywords
solns
diabetic
treatment
alcoholic
thioctic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09302159A
Other languages
English (en)
Other versions
ES2063713B1 (es
Inventor
Helmut Hettche
Reinhard Muckenschnabel
Jurgen Engel
Heinz Ulrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Publication of ES2063713A1 publication Critical patent/ES2063713A1/es
Application granted granted Critical
Publication of ES2063713B1 publication Critical patent/ES2063713B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

AMPOLLA Y SOLUCION PARA INFUSION DE ACIDO TIOCTICO EN FORMA DE LAS SALES SOLUBLES EN AGUA DEL ACIDO TIOCTICO. SE DESCRIBEN NUEVAS FORMAS MEDICAMENTOSAS QUE CONTIENEN 0,4 A 16 G/LITRO DE ACIDO TIOCTICO Y UNA AMPOLLA CON 300-800 MG DE ACIDO TIOCTICO.
ES09302159A 1992-10-15 1993-10-14 Ampolla y solucion para infusion de acido tioctico en forma de las sales solubles en agua del acido tioctico. Expired - Fee Related ES2063713B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE9213914U DE9213914U1 (de) 1992-10-15 1992-10-15 Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure

Publications (2)

Publication Number Publication Date
ES2063713A1 true ES2063713A1 (es) 1995-01-01
ES2063713B1 ES2063713B1 (es) 1995-07-16

Family

ID=6884846

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09302159A Expired - Fee Related ES2063713B1 (es) 1992-10-15 1993-10-14 Ampolla y solucion para infusion de acido tioctico en forma de las sales solubles en agua del acido tioctico.

Country Status (7)

Country Link
BE (1) BE1007420A3 (es)
DE (1) DE9213914U1 (es)
ES (1) ES2063713B1 (es)
FR (1) FR2696933B3 (es)
IT (1) IT1260996B (es)
NL (1) NL9301781A (es)
PT (1) PT101388B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE29506604U1 (de) * 1995-04-25 1995-06-14 Asta Medica Ag, 01277 Dresden Fertiginfusionsset
ITMI20111975A1 (it) * 2011-10-28 2013-04-29 Labomar S R L Composizioni comprendenti un sale di un acido organico.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1095991B (de) * 1959-05-09 1960-12-29 Chemiewerk Homburg Zweignieder Verfahren zur Herstellung einer stabilen und injizierbaren 1,2-Dithia-cyclopentan-3-valeriansaeure enthaltenden Loesung
DE1668887A1 (de) * 1968-03-15 1971-07-01 Degussa Calciumthioctat
FR2559668A1 (fr) * 1984-02-17 1985-08-23 Dobrivoje Tomic Compositions pharmaceutiques pour le traitement du diabete et de maladies et defauts de fonctionnement du foie
ES8703451A1 (es) * 1985-04-11 1987-02-16 Degussa Procedimiento para preparar acido 1,2-ditiolan-3-pentanoico (acido tioctico)
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS3814940B1 (es) * 1961-03-04 1963-08-15
JPS3922715B1 (es) * 1962-03-29 1964-10-13
JPS4526516B1 (es) * 1968-07-08 1970-09-01
JPS6066955A (ja) * 1983-09-19 1985-04-17 Kiyaraban:Kk ドレッシングの製造方法
CH684054A5 (de) * 1989-11-09 1994-07-15 Asta Medica Ag Arzneimittel, welche als Wirkstoff Schwefel enthaltende Carbonsäuren enthalten.
ES2115589T3 (es) * 1989-11-09 1998-07-01 Asta Medica Ag Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1095991B (de) * 1959-05-09 1960-12-29 Chemiewerk Homburg Zweignieder Verfahren zur Herstellung einer stabilen und injizierbaren 1,2-Dithia-cyclopentan-3-valeriansaeure enthaltenden Loesung
DE1668887A1 (de) * 1968-03-15 1971-07-01 Degussa Calciumthioctat
FR2559668A1 (fr) * 1984-02-17 1985-08-23 Dobrivoje Tomic Compositions pharmaceutiques pour le traitement du diabete et de maladies et defauts de fonctionnement du foie
ES8703451A1 (es) * 1985-04-11 1987-02-16 Degussa Procedimiento para preparar acido 1,2-ditiolan-3-pentanoico (acido tioctico)
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.

Also Published As

Publication number Publication date
IT1260996B (it) 1996-04-29
FR2696933A3 (fr) 1994-04-22
BE1007420A3 (fr) 1995-06-13
PT101388B (pt) 1999-09-30
PT101388A (pt) 1994-09-30
DE9213914U1 (de) 1992-12-03
ES2063713B1 (es) 1995-07-16
FR2696933B3 (fr) 1994-09-23
ITTO930761A1 (it) 1995-04-15
NL9301781A (nl) 1994-05-02
ITTO930761A0 (it) 1993-10-15

Similar Documents

Publication Publication Date Title
US4851444A (en) Onset-hastened/enhanced analgesia
EP0465508A4 (en) Dietary supplement for insulin-resistant diabetics
IL104450A0 (en) Pharmaceutical compositions containing 9-cis retinoic acid or a salt or ester thereof
ATE216230T1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
AU5549586A (en) Therapeutic use of tin mesoporphyrin
DK0787489T3 (da) Sammensætning, der indeholder propionyl-L-carnitin og hydroxycitronsyre eller pantothensyre
PT935961E (pt) Sais de ácido (r)-2-(3-benzoilfenil) propiónico e preparações farmacêuticas que os contêm
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
AU6346586A (en) Therapeutic agents
US4980375A (en) Onset-hastened/enhanced antipyretic response
AU6048086A (en) Bactericidal formulations for use in the area of veterinary medicine
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
CA2004332A1 (en) Inhibition of cell adhesion
JPS56145298A (en) Aminophenyl derivative and physiologically active preparation containing the same
IE59635B1 (en) Irom-containing composition and method for treatment of cancer
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
AU669946B2 (en) Lanolin/lanolin acid ester skin treatment composition
US4483854A (en) Systemic treatment of psoriasis using certain salicylates
IE35599L (en) 2-phenylbenzoxazoles.
Ward et al. Ethanol and leucine oxidation--II. Leucine oxidation by rat tissue in vitro
Fretland et al. SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12 (R)-hydroxyeicosatetraenoic acid
FR2515962A1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
Miller et al. Metabolism of cardiac muscle. VII. The effect of inhibitors on the metabolism of pyruvate and dl-lactate
GB2208798B (en) Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
JPS6450817A (en) Agent for reducing blood viscosity

Legal Events

Date Code Title Description
PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20141120